These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 14767285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
    Bader P, Burkhard FC, Markwalder R, Studer UE.
    J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Cheng L, Bostwick DG.
    J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
    Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML.
    J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
    [Abstract] [Full Text] [Related]

  • 10. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC.
    Cancer; 2007 Apr 01; 109(7):1273-8. PubMed ID: 17315165
    [Abstract] [Full Text] [Related]

  • 11. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy.
    Schumacher MC, Burkhard FC, Thalmann GN, Fleischmann A, Studer UE.
    Eur Urol; 2008 Aug 01; 54(2):344-52. PubMed ID: 18511183
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D, Goppelt M, Dorn R, Wawroschek F, Harzmann R.
    BJU Int; 2006 Jun 01; 97(6):1173-8. PubMed ID: 16686707
    [Abstract] [Full Text] [Related]

  • 16. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate.
    Oefelein MG, Smith ND, Grayhack JT, Schaeffer AJ, McVary KT.
    J Urol; 1997 Oct 01; 158(4):1460-5. PubMed ID: 9302143
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer.
    Weight CJ, Reuther AM, Gunn PW, Zippe CR, Dhar NB, Klein EA.
    Urology; 2008 Jan 01; 71(1):141-5. PubMed ID: 18242383
    [Abstract] [Full Text] [Related]

  • 20. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA.
    Urology; 2004 Mar 01; 63(3):528-31. PubMed ID: 15028451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.